医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SCA Integrates Its Business in the Middle East, India and Africa into Consumer Goods

2016年08月22日 PM06:14
このエントリーをはてなブックマークに追加


 

STOCKHOLM

SCA (STO:SCAA) (STO:SCAB) will integrate its Business Unit MEIA (Middle East, India and Africa) into Business Unit Consumer Goods to leverage our scale and capabilities and to further increase efficiency. Combining these organizations will help to capture synergies and facilitate best practice sharing within the consumer business.

“This integration provides us with the scale to stay competitive in a region to which we are committed and creates a strong foundation for future profitable growth” commented Magnus Groth, CEO and President of SCA.

Volker Zöller, President, SCA Consumer Goods explained: “We aspire to implement the relevant parts of our successful European Go-To-Market program in MEIA and to leverage innovation on a broader scale”.

The integration will be effective as of November 1, 2016.

Business Unit MEIA offers Personal Care products and Tissue in the regions Middle East, India and Africa. The business unit accounted for 2% of the Group’s net sales for the first quarter of 2016. Business unit Consumer Goods, which offers consumer goods in Europe, accounted for 30% during the same period.

SCA is a leading global hygiene and forest products company. The Group develops and produces sustainable personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands, including the leading global brands TENA and Tork, and regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. The Group has about 44,000 employees. Sales in 2015 amounted to approximately SEK 115bn (EUR 12.3bn). SCA was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed on NASDAQ OMX Stockholm. For more information, visit www.sca.com.

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160822005347/en/

CONTACT

SCA
Linda Nyberg
VP Media Relations and Online Communications
46
8 788 51 58
or
Johan Karlsson
VP Investor Relations
46
8 788 51 30

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 苏尔寿:IDS 2017出现仿冒品和专利侵权者——苏尔寿混合技术有限公司将继续行使其权利
  • New CDISC Standard Empowers Smarter Research for Diabetic Kidney Disease
  • Dr. Reddy’s and CHD Bioscience Announce Global License and Commercialization Agreement for Phase III Clinical Trial Candidate for Mitigation of Surgical Site Infections
  • Dr. Reddy’s Q1 FY18 Financial Results
  • Cogstate Receives Positive FDA Notification Regarding Medical Device Regulatory Submission